arrow
J

Jeanette Reinshagen

fraunhofer institute for translational medicine and pharmacology
H指数:18
被引数:934

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The fast-dissociating D2 antagonist antipsychotic JNJ-37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment

快速解离的D2拮抗剂型抗精神病药JNJ-37822681是一种神经元Kv7通道开放剂:用于癫痫治疗的潜在再利用

2025-07-230
OAAI
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic Agents
2023-11-033
OAAI
ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1
2023-09-2912
OAAI
A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization
2021-05-2610
OAAI
Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics

通过药物化学,筛选和基因组学的应用,在利什曼原虫中发现苯并噻吩-黄酮醇可阻止米替福新和锑耐药性

2019-12-0121
PREAI
Activation of Caspase-6 Is Promoted by a Mutant Huntingtin Fragment and Blocked by an Allosteric Inhibitor Compound
2019-09-0115
OAAI
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent

作为抗布氏锥虫剂的Chromen-4-one衍生物的SAR研究和生物学特性

2019-01-297
OAAI
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery

利用2-氨基-1,3,4-噻二唑支架抑制布氏锥虫蝶啶还原酶以支持早期药物发现

2017-09-1129
OAAI
Methoxylated 2′-hydroxychalcones as antiparasitic hit compounds

甲氧基化2 ′-羟基查耳酮作为抗寄生虫化合物

2017-01-0123
OAAI
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs

用于开发抗锥虫病药物的黄酮醇衍生物的分析

2016-08-0542
OAAI